United States Oncology Information Systems Market By Products & Services, By Application, By End Use, By Region and Competition, Forecast & Opportunities, 2020-2030F

The United States Oncology Information Systems (OIS) Market was valued at USD 912.11 million in 2024 and is projected to reach USD 1404.16 million by 2030, growing at a CAGR of 7.43%. This market is evolving rapidly as cancer care becomes more complex and healthcare providers seek integrated digital solutions to streamline clinical operations. OIS platforms unify diverse functionalities-including medical imaging, chemotherapy and radiation therapy planning, and electronic health records-into a centralized system to enhance treatment accuracy and patient coordination. Rising cancer incidence and the demand for multidisciplinary and personalized treatment strategies are key growth drivers, prompting increased adoption of advanced IT tools. Additionally, artificial intelligence, predictive analytics, and cloud-based deployment models are shaping next-generation oncology systems. With value-based care and regulatory digitalization initiatives pushing healthcare modernization, OIS platforms are becoming indispensable for improving both clinical performance and operational efficiency in the U.S. oncology landscape.

Key Market Drivers

Increasing Cancer Incidence and Rising Patient Load

The rising cancer burden in the United States is a primary driver for the Oncology Information Systems (OIS) Market. With over 2 million new cancer cases projected in 2024 across major types such as breast, prostate, lung, and colorectal cancers, healthcare providers are increasingly relying on OIS to manage the growing volume and complexity of cancer care. These systems enhance workflow efficiency and clinical accuracy by offering real-time access to comprehensive patient data, supporting seamless collaboration across oncology teams, and integrating with broader healthcare IT systems. As modern treatments grow more intricate-featuring immunotherapy and precision medicine-OIS platforms are vital for handling diverse modalities and tracking individualized treatment outcomes. Moreover, these systems help address rising patient loads by improving resource management, minimizing delays in care, and supporting regulatory and reimbursement requirements. Their role in ensuring timely, coordinated, and effective cancer treatment reinforces their critical value in a growing oncology care environment.

Key Market Challenges

High Implementation and Maintenance Costs

The substantial cost of implementing and maintaining Oncology Information Systems (OIS) presents a significant challenge in the U.S. market. Establishing an OIS infrastructure entails high initial investments in software, hardware, and integration services, particularly when aligning with legacy systems and regulatory standards. For smaller healthcare providers and rural centers, these expenses can inhibit adoption. Beyond implementation, ongoing maintenance costs-including regular software updates, cybersecurity, and technical support-further strain operational budgets. The need for specialized IT personnel or outsourced support also adds to long-term financial commitments. Given the critical nature of oncology care, ensuring continuous system uptime and secure patient data access is essential, necessitating robust maintenance protocols. Additionally, maintaining compliance with evolving data privacy regulations and ensuring interoperability across systems increases the complexity and cost of ownership, making affordability a key barrier to widespread adoption.

Key Market Trends

Growing Adoption of Cloud-Based Oncology Information Systems

A prominent trend in the U.S. Oncology Information Systems Market is the increasing shift toward cloud-based platforms. These systems offer healthcare providers a cost-effective, scalable, and flexible alternative to traditional on-premises infrastructure. Cloud deployment supports seamless data access and collaboration among multidisciplinary teams, especially in geographically dispersed cancer care facilities. The model also minimizes upfront infrastructure costs and reduces IT maintenance burdens, making it especially appealing to smaller providers. Enhanced cybersecurity measures and regular software updates are managed centrally by cloud service providers, ensuring data protection and regulatory compliance. Furthermore, cloud platforms improve interoperability, allowing easy integration with EHRs, imaging systems, and lab databases to create a unified patient record. This connectivity supports precision treatment planning, enhances care coordination, and facilitates participation in value-based care models. The agility and efficiency of cloud-based OIS systems are redefining how oncology services are delivered in a rapidly evolving healthcare environment.

Key Market Players

• Elekta AB
• Accuray Incorporated
• RaySearch Laboratories
• Cerner Corporation
• BrainLab
• Philips Healthcare
• Prowess, Inc.
• DOSIsoft S.A.
• ViewRay Inc.
• MIM Software

Report Scope:

In this report, the United States Oncology Information Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

United States Oncology Information Systems Market, By Products & Services:

• Software
• Professional Services

United States Oncology Information Systems Market, By Application:

• Medical Oncology
• Radiation Oncology
• Surgical Oncology

United States Oncology Information Systems Market, By End Use:

• Hospitals & Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

United States Oncology Information Systems Market, By Region:

• North-East
• Mid-West
• West
• South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States Oncology Information Systems Market.

Available Customizations:

United States Oncology Information Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).